Effect of tanshinone ⅡA on COX-2 expression in hepatocellular carcinoma cell line SMMC-7721
Jun-Li Xu,Shui-Xiang He,Jing-Hong Chen,Han Fu,Gang Zhao,Yan-Li Wang,Mu-Dan Ren
DOI: https://doi.org/10.3969/j.issn.1009-3079.2006.14.004
2006-01-01
World Chinese Journal of Digestology
Abstract:AIM: To observe the effect of Tanshinone ⅡA on the proliferation and apoptosis of human hepatocellular carcinoma cell line SMMC-7721 and its machanism. METHODS: The human hepatocellular carcinoma cell line SMMC-7721 cultured in vitro was treated with different concentrations (final 0.5 mg/L) Tanshinone ⅡA. The proliferation of the cells was measured by MTT assay, and the apoptosis of the cells was investigated by flow cytometry and transmission electron microscopy (TEM). The expression of Cyclooxygenase-2 (COX-2) was detected by immunocytochemistry. The levels of prostaglandin E2 (PGE2) in medium were measured by radioimmunoassay. RESULTS: Tanshinone ⅡA inhibited the growth of SMMC-7721 cells in a dose-dependent manner. The inhibitory rate reached the peak (69.3%) after 0.5 mg/L Tanshinone ⅡA was used for 48 h, which was significantly higher than that in the controls (P < 0.01). Typical features of apoptosis as cell shrinkage, nuclear chromatin condensation, fragmentation, and the formation of apoptotic bodies was found by TEM in the cells treated with Tanshinone ⅡA. FCM analysis showed the apoptotic rates for 24, 48 and 72 h were 7.45%±0.33%,6.59%±0.45%, and 4.78%± 1.05%, respectively, when 5 mg/L Tanshinone ⅡA was used, which were markedly higher than those in the controls (all P < 0.01). Both the expression of COX-2 (P < 0.01) and the production of PGE2 (40.18±1.37 μg/L vs 75.31±1.64 μg/L, P<0.01) were decreased significantly after Tanshinone ⅡA treatment as compared with those in the controls. CONCLUSION: Tanshinone ⅡA inhibits the proliferation and increases the apoptosis of human hepatocellular carcinoma cell line SMMC-7721 by down-regulation of COX-2 protein expression.